Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Switzerland first to pass European Commission's GMP equivalence test for drug APIs

This article was originally published in SRA

Executive Summary

Switzerland has become the first country to receive an "equivalence" rating from the European Commission for its regulatory framework on active pharmaceutical ingredients (APIs)1,2. This means that the country will not have to confirm in writing that individual consignments of Swiss-manufactured APIs imported into the EU match up to the latter's good manufacturing practice standards.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS117050

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel